Table 1 Clinical characteristics of patients undergoing heart-valve surgery
From: Expression of ceramide-metabolising enzymes in subcutaneous and intra-abdominal human adipose tissue
Males | Females | |
|---|---|---|
n = 14 | n = 9 | |
Age (years) | 64.8 ± 3.9 | 68.8 ± 3.3 |
BMI (kg/m2) | 27.2 ± 1.0 | 26.5 ± 1.3 |
Glucose (mmol/l) | 5.0 ± 0.1 | 5.2 ± 0.2 |
HbA1c (%) | 4.4 ± 0.1 | 4.7 ± 0.1* |
Insulin (pmol/l) | 56.2 ± 10.5 | 49.6 ± 8.6 |
Triacylglycerol (mmol/l) | 1.2 ± 0.2 | 0.9 ± 0.1 |
Total-cholesterol (mmol/l) | 5.1 ± 0.2 | 4.7 ± 0.4 |
LDL-cholesterol (mmol/l) | 3.4 ± 0.2 | 2.7 ± 0.3 |
HDL-cholesterol (mmol/l) | 1.2 ± 0.1 | 1.6 ± 0.2* |
ALAT (μkat/l) | 0.50 ± 0.04 | 0.41 ± 0.04 |
γGT (μkat/l) | 0.45 ± 0.11 | 0.48 ± 0.20 |
CRP (mg/l) | 2.9 ± 0.6 | 2.6 ± 1.0 |